JACQUELINE BENNER: Open Payments
NPI 1730376229 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,817 in 98 payments from 16 companies in 2025. Trend: 2023 $660 · 2024 $1,215 · 2025 $1,817
Food & beverage: $1,667Education: $150
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $358 |
| Janssen Biotech, Inc. | 13 | $266 |
| Incyte Corporation | 13 | $192 |
| E.R. Squibb & Sons, L.L.C. | 11 | $168 |
| Novartis Pharmaceuticals Corporation | 17 | $168 |
| Lilly USA, LLC | 6 | $115 |
| ABBVIE INC. | 5 | $113 |
| Regeneron Healthcare Solutions, Inc. | 5 | $107 |
| Amgen Inc. | 4 | $85 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
Products named: DUPIXENT, TREMFYA, OPZELURA, Sotyktu, COSENTYX, SKYRIZI, TALTZ, OTEZLA.
Industry payments across MI — which companies pay providers there.
